Sociodemographic Factors May Affect Early Treatment of Pancreatic Cancer

Share this content:
Sociodemographic factors affect the odds of pancreatic cancer resection.
Sociodemographic factors affect the odds of pancreatic cancer resection.

Sociodemographic factors, such as residential instability, low income, and living in a rural area, negatively affect the odds of a patient with pancreatic cancer undergoing surgical resection, even in a single-payer universal health care system, according to an article published in Cancer.1

Researchers analyzed the treatment implications of sociodemographic status by enrolling 6296 patients, each of whom was diagnosed with pancreatic cancer between 2005 and 2010.

Of these patients, 820 underwent surgical resection. Residential instability, material deprivation, low income, and living in a rural area were each associated with a reduced likelihood of undergoing the operation. There was not, however, an association made between sociodemographic factors and receipt of adjuvant therapy.

RELATED: 25(OH)D Levels Linked to Survival in Pancreatic Cancer

The authors concluded that the analyzed sociodemographic factors influenced care early in pancreatic cancer treatment only. Census data were used to determine values for the analyzed factors.


1. Kagedan DJ, Abraham L, Goyert N, et al. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer. Cancer. 8 Jul 2016. doi: 10.1002/cncr.30148 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs